Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 33 studies | 42% ± 20% | |
pericyte | 31 studies | 39% ± 17% | |
smooth muscle cell | 28 studies | 37% ± 17% | |
endothelial cell of lymphatic vessel | 21 studies | 41% ± 16% | |
fibroblast | 16 studies | 28% ± 12% | |
capillary endothelial cell | 16 studies | 43% ± 20% | |
basal cell | 16 studies | 38% ± 16% | |
endothelial cell of vascular tree | 15 studies | 39% ± 17% | |
type I pneumocyte | 12 studies | 67% ± 17% | |
endothelial cell of artery | 12 studies | 52% ± 13% | |
vein endothelial cell | 12 studies | 42% ± 12% | |
adipocyte | 9 studies | 44% ± 16% | |
mesothelial cell | 8 studies | 34% ± 16% | |
myofibroblast cell | 8 studies | 37% ± 13% | |
epithelial cell | 8 studies | 27% ± 9% | |
secretory cell | 7 studies | 31% ± 15% | |
club cell | 5 studies | 34% ± 16% | |
cardiac muscle cell | 5 studies | 40% ± 5% | |
connective tissue cell | 4 studies | 32% ± 16% | |
ciliated cell | 4 studies | 29% ± 17% | |
myoepithelial cell | 4 studies | 36% ± 8% | |
keratinocyte | 4 studies | 28% ± 8% | |
ionocyte | 3 studies | 23% ± 7% | |
astrocyte | 3 studies | 42% ± 12% | |
Mueller cell | 3 studies | 40% ± 4% | |
muscle cell | 3 studies | 40% ± 21% | |
pancreatic ductal cell | 3 studies | 70% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 10709.10 | 651 / 653 | 95% | 103.18 | 574 / 605 |
esophagus | 99% | 4891.49 | 1436 / 1445 | 95% | 59.92 | 174 / 183 |
lung | 100% | 11737.45 | 578 / 578 | 91% | 47.23 | 1054 / 1155 |
skin | 100% | 5571.77 | 1800 / 1809 | 87% | 28.88 | 412 / 472 |
uterus | 98% | 4594.96 | 166 / 170 | 78% | 33.11 | 359 / 459 |
bladder | 100% | 4750.62 | 21 / 21 | 67% | 28.56 | 338 / 504 |
breast | 100% | 10039.28 | 459 / 459 | 66% | 14.05 | 734 / 1118 |
pancreas | 65% | 1288.98 | 214 / 328 | 96% | 46.57 | 170 / 178 |
ovary | 99% | 3225.92 | 178 / 180 | 56% | 10.11 | 239 / 430 |
prostate | 96% | 3110.89 | 235 / 245 | 52% | 8.22 | 263 / 502 |
liver | 69% | 1366.82 | 157 / 226 | 67% | 25.31 | 273 / 406 |
kidney | 38% | 788.42 | 34 / 89 | 97% | 69.00 | 876 / 901 |
intestine | 83% | 3592.83 | 800 / 966 | 43% | 12.01 | 224 / 527 |
stomach | 58% | 1853.42 | 210 / 359 | 53% | 14.22 | 153 / 286 |
adipose | 100% | 12335.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9514.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.83 | 1 / 1 |
heart | 100% | 7607.13 | 858 / 861 | 0% | 0 | 0 / 0 |
spleen | 99% | 3172.36 | 238 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 36.00 | 41 / 45 |
adrenal gland | 46% | 856.43 | 119 / 258 | 25% | 5.29 | 57 / 230 |
eye | 0% | 0 | 0 / 0 | 43% | 6.52 | 34 / 80 |
brain | 14% | 275.78 | 381 / 2642 | 27% | 6.75 | 189 / 705 |
muscle | 33% | 588.67 | 261 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0060161 | Biological process | positive regulation of dopamine receptor signaling pathway |
GO_0014859 | Biological process | negative regulation of skeletal muscle cell proliferation |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0014856 | Biological process | skeletal muscle cell proliferation |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0007029 | Biological process | endoplasmic reticulum organization |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0044794 | Biological process | positive regulation by host of viral process |
GO_0070836 | Biological process | caveola assembly |
GO_0071711 | Biological process | basement membrane organization |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0007005 | Biological process | mitochondrion organization |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0030154 | Biological process | cell differentiation |
GO_0016050 | Biological process | vesicle organization |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0048278 | Biological process | vesicle docking |
GO_0019065 | Biological process | receptor-mediated endocytosis of virus by host cell |
GO_0019076 | Biological process | viral release from host cell |
GO_0006906 | Biological process | vesicle fusion |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0002080 | Cellular component | acrosomal membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0044853 | Cellular component | plasma membrane raft |
GO_0000139 | Cellular component | Golgi membrane |
GO_0002095 | Cellular component | caveolar macromolecular signaling complex |
GO_0030133 | Cellular component | transport vesicle |
GO_0005901 | Cellular component | caveola |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CAV2 |
Protein name | Caveolin-2 Caveolin |
Synonyms | hCG_39087 tcag7.25 |
Description | FUNCTION: May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. The Ser-36 phosphorylated form has a role in modulating mitosis in endothelial cells. Positive regulator of cellular mitogenesis of the MAPK signaling pathway. Required for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, and the subsequent regulation of cell cycle progression (By similarity). . FUNCTION: May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. The Ser-36 phosphorylated form has a role in modulating mitosis in endothelial cells. Positive regulator of cellular mitogenesis of the MAPK signaling pathway. Required for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, and the subsequent regulation of cell cycle progression. . FUNCTION: May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. The Ser-36 phosphorylated form has a role in modulating mitosis in endothelial cells. Positive regulator of cellular mitogenesis of the MAPK signaling pathway. Required for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, and the subsequent regulation of cell cycle progression. . |
Accessions | ENST00000343213.2 [P51636-3] ENST00000222693.5 [P51636-1] Q53X57 ENST00000393480.3 E9PCT3 P51636 |